APPROVALS

Roche is acquiring Foundation Medicine for $2.4 billion in a bid to bolster its efforts in the personal healthcare space. Daniel O’Day, CEO Roche Pharmaceuticals,...

Amgen has secured a full marketing authorisation in Europe for Blincyto, the first-and-only approved bispecific CD19-directed CD3 T cell engager (BiTE®) immunotherapy. The European Commission...

French pharma giant Sanofi has confirmed that it has completed its €3.9 billion acquisition of Ablynx. The deal, originally announced back in January, sees Sanofi...